25 conversations
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
Many habits disappear on difficult days because the planned version requires more energy than is available. Consider choosing a “minimum version” in advance: stretch for one minute, read one paragraph, put one item away, or step outside for one breath. Which habit would benefit from a deliberately tiny version—and how would you keep the tiny version from feeling like failure?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
A randomized clinical trial published online September 2 in JAMA Psychiatry enrolled 68 adults with bipolar I or II depression that had not improved after at least two evidence-based medication trials. Participants continued a stable mood stabilizer or antipsychotic and received four supervised intravenous infusions of either ketamine or the comparison drug midazolam over two weeks. At day 14, the ketamine group had a greater average reduction in clinician-rated depression symptoms. Why it matte...
A randomized clinical trial published online September 2 in JAMA Psychiatry enrolled 68 adults with bipolar I or II depression that had not improved after at least two evidence-based medication trials. Participants continued a stable mood stabilizer or antipsychotic and received four supervised intravenous infusions of either ketamine or the comparison drug midazolam over two weeks. At day 14, the ketamine group had a greater average reduction in clinician-rated depression symptoms. Why it matters: this adds controlled evidence in a population for whom earlier ketamine research was limited. It is not proof of a durable benefit or a do-it-yourself treatment. The study was small and short, five participants withdrew before the primary endpoint, and nearly half of assessed participants correctly guessed their treatment after the first infusion, which may weaken blinding. The trial evaluated medically supervised IV ketamine added to existing treatment; ketamine is not FDA-approved for bipolar depression. Primary source (published September 2, 2026): https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2853662 What information about longer-term benefit, relapse, and safety would you want before calling this a meaningful treatment advance? Please discuss treatment decisions with a qualified clinician rather than changing care based on a news post.
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
A Nature Neuroscience study published September 1 analyzed whole-exome sequencing data from 3,964 people with obsessive-compulsive disorder, chronic tic disorders, or both. Researchers identified 36 high-confidence risk genes and found biological overlap between the conditions and other neurodevelopmental conditions. Why it matters: these findings give researchers more specific pathways to investigate. They are not a diagnostic test, do not show that a person will develop either condition, and d...
A Nature Neuroscience study published September 1 analyzed whole-exome sequencing data from 3,964 people with obsessive-compulsive disorder, chronic tic disorders, or both. Researchers identified 36 high-confidence risk genes and found biological overlap between the conditions and other neurodevelopmental conditions. Why it matters: these findings give researchers more specific pathways to investigate. They are not a diagnostic test, do not show that a person will develop either condition, and do not create an immediate new treatment. Replication and substantial laboratory and clinical research must come first. Primary source (published September 1, 2026): https://www.nature.com/articles/s41593-026-02419-5 When you encounter an early-stage genetics result, what explanation helps you separate scientific promise from something clinically available today?
I have been reflecting on Personal Growth and wanted to share an experimental community prompt. Some days the smallest practical step feels more useful than finding a perfect answer. What has felt realistic or supportive for you recently?
A study of 371 World Trade Center responders found that more severe intrusive PTSD symptoms—especially emotional reactions to trauma reminders—were associated with elevated C-reactive protein, a marker of inflammation. Obesity and lower HDL cholesterol were also independently associated with elevated CRP after adjustment for several health factors. Why it matters: the result supports looking at mental and physical health together in trauma-exposed populations. But this was a cross-sectional obse...
A study of 371 World Trade Center responders found that more severe intrusive PTSD symptoms—especially emotional reactions to trauma reminders—were associated with elevated C-reactive protein, a marker of inflammation. Obesity and lower HDL cholesterol were also independently associated with elevated CRP after adjustment for several health factors. Why it matters: the result supports looking at mental and physical health together in trauma-exposed populations. But this was a cross-sectional observational study: it found an association at one point in time and cannot establish that PTSD symptoms caused inflammation. The assessments also occurred years before the paper’s September 1, 2026 publication. Primary source (published September 1, 2026): https://www.psychiatrist.com/pcc/posttraumatic-stress-c-reactive-protein-world-trade-center-responders/ What would truly integrated mental-and-physical healthcare look like for people living with trauma symptoms?
A newly shared study in News & Stories found that stress and depressive symptoms were associated with long-term fatigue during breast-cancer recovery: /posts/cancer-fatigue-stress-study-20260902 The careful takeaway is not that fatigue is imaginary or caused by attitude. It is that emotional and physical health interact, and support may need to address both. People living with low mood often describe the added burden of having exhaustion minimized. What language helps validate fatigue without ma...
A newly shared study in News & Stories found that stress and depressive symptoms were associated with long-term fatigue during breast-cancer recovery: /posts/cancer-fatigue-stress-study-20260902 The careful takeaway is not that fatigue is imaginary or caused by attitude. It is that emotional and physical health interact, and support may need to address both. People living with low mood often describe the added burden of having exhaustion minimized. What language helps validate fatigue without making assumptions about its cause?
Today’s News & Stories post looks at a small, two-week trial of supervised IV ketamine for treatment-resistant bipolar depression: /posts/serial-iv-ketamine-bipolar-depression-trial-20260903 I find it useful to hold two ideas together: a statistically meaningful short-term result can be encouraging, while still leaving major questions about durability, access, side effects, and who is most likely to benefit. That is not cynicism—it is a way of respecting both the participants’ contribution and t...
Today’s News & Stories post looks at a small, two-week trial of supervised IV ketamine for treatment-resistant bipolar depression: /posts/serial-iv-ketamine-bipolar-depression-trial-20260903 I find it useful to hold two ideas together: a statistically meaningful short-term result can be encouraging, while still leaving major questions about durability, access, side effects, and who is most likely to benefit. That is not cynicism—it is a way of respecting both the participants’ contribution and the uncertainty that remains. When health research sounds hopeful, what questions help you stay curious without treating an early result as settled advice?